Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Eastell

Showing results (1-10 of 346) with videos related to

Pageof 35
Sort By:
The Journal of Clinical Endocrinology and Metabolism|January 9, 2007
Breast cancer and the risk of osteoporotic fracture: A paradoxRichard Eastell
Medical and Pediatric Oncology|July 18, 2003
Management of osteoporosis due to ovarian failureRichard Eastell
Nature Clinical Practice. Endocrinology & Metabolism|September 8, 2006
Does warfarin increase the risk of osteoporotic fracture?Richard Eastell
The Journal of Endocrinology|April 23, 2005
Role of oestrogen in the regulation of bone turnover at the menarcheRichard Eastell
The Journal of Steroid Biochemistry and Molecular Biology|July 24, 2007
Aromatase inhibitors and boneRichard Eastell
Hormone Research|November 16, 2005
Management of bone health in postmenopausal womenRichard Eastell
The Lancet. Diabetes & Endocrinology|July 11, 2017
Use of bone turnover markers in postmenopausal osteoporosisRichard Eastell, Pawel Szulc
Bone|April 3, 2020
The challenge of long-term adherence: The role of bone turnover markers in monitoring bisphosphonate treatment of osteoporosisAndreas Fontalis, Richard Eastell
Current Osteoporosis Reports|December 13, 2023
Efficacy of Osteoporosis Medications in Patients with Type 2 DiabetesTatiane Vilaca, Richard Eastell
JBMR Plus|November 29, 2023
Antiresorptive Versus Anabolic Therapy in Managing Osteoporosis in People with Type 1 and Type 2 DiabetesTatiane Vilaca, Richard Eastell
Pageof 35

Showing results (1-10 of 346) with videos related to

Sort By:
Pageof 35
The Journal of Clinical Endocrinology and Metabolism|January 9, 2007
Breast cancer and the risk of osteoporotic fracture: A paradoxRichard Eastell
Medical and Pediatric Oncology|July 18, 2003
Management of osteoporosis due to ovarian failureRichard Eastell
Nature Clinical Practice. Endocrinology & Metabolism|September 8, 2006
Does warfarin increase the risk of osteoporotic fracture?Richard Eastell
The Journal of Endocrinology|April 23, 2005
Role of oestrogen in the regulation of bone turnover at the menarcheRichard Eastell
The Journal of Steroid Biochemistry and Molecular Biology|July 24, 2007
Aromatase inhibitors and boneRichard Eastell
Hormone Research|November 16, 2005
Management of bone health in postmenopausal womenRichard Eastell
The Lancet. Diabetes & Endocrinology|July 11, 2017
Use of bone turnover markers in postmenopausal osteoporosisRichard Eastell, Pawel Szulc
Bone|April 3, 2020
The challenge of long-term adherence: The role of bone turnover markers in monitoring bisphosphonate treatment of osteoporosisAndreas Fontalis, Richard Eastell
Current Osteoporosis Reports|December 13, 2023
Efficacy of Osteoporosis Medications in Patients with Type 2 DiabetesTatiane Vilaca, Richard Eastell
JBMR Plus|November 29, 2023
Antiresorptive Versus Anabolic Therapy in Managing Osteoporosis in People with Type 1 and Type 2 DiabetesTatiane Vilaca, Richard Eastell
Pageof 35